Form 4: USANA Health Sciences Officer Daniel A. Macuga Reports Sale of Common Stock
SEC Form 4 Filing
Daniel A. Macuga, Chief Communications Officer of USANA Health Sciences, reported the sale of 1,500 shares of common stock on March 1, 2024.
Summary
- On March 1, 2024, Daniel A. Macuga, Chief Communications Officer of USANA Health Sciences, sold 1,500 shares of the company's common stock.
- The sale price was $48.08 per share.
- Following the transaction, Macuga directly owns 3,791 shares of USANA Health Sciences common stock.
Sentiment
Score: 5
Explanation: This is a neutral document reporting a stock sale by an officer. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This is a routine disclosure of an insider transaction. It's common for company executives to buy and sell shares of their company's stock. The reasons for the transaction are not disclosed in this document.
Stakeholder Impact
- The sale of shares by a company officer could be perceived negatively by some shareholders, although the impact is likely minimal given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of transaction: Sale of 1,500 shares of common stock. |
| 03/04/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.